Caliper Life Sciences CEO to Present Keynote Presentation at MipTec European Conference

HOPKINTON, Mass., Sept. 20 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that Kevin Hrusovsky, President and CEO of Caliper will be providing a keynote presentation this week at the MipTec conference in Basel, Switzerland. This invited presentation, entitled "Next Generation Tools Revolutionizing Medicine," is scheduled for Tuesday September 21, 2010 and will highlight key trends that are transforming "sick care" to "health care" and immensely impacting biopharmaceutical research.

"Advanced technologies will continue to give progressive organizations a competitive advantage in the rapidly changing medical industry," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "The use of molecular imaging and microfluidics will continue to play a critical role in the development of biomarkers for use as companion diagnostics, in biotherapeutics commercialization, and in the delivery of personalized medicine. These key themes, coupled with innovations in sequencing technology, vaccine development and stem cells are revolutionizing the global practice of healthcare."

About MipTec

MipTec is the premier European conference and exhibition encompassing innovative approaches to high quality science and technology for efficient drug discovery. The mission of MipTec is to bring together scientists from all disciplines involved in drug discovery within pharmaceutical and biotech companies, academic labs and technology providers in an atmosphere where ideas and experiences are shared and discussed. This atmosphere is created through a scientific program covering key topics and the latest breakthroughs in the diverse fields that make up drug discovery.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper is a registered trademark of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED